Indeed, some of the beneficial cardiovascular effects of long-chain omega-3 PUFA and especially EPA, at least those mediated by CYP450/sEH metabolites, could act as compensatory mechanism and thus being more evident in more disadvantageous conditions, that is, obesity together with high blood pressure. This evidence concerns the gene EPHX2 and hypertensive disorder.